**4. Voluntary interruption of pregnancy**

It has been documented that a parallel increase in pregnancy interruption occurred with fetal CHD diagnosis [9]. Thus, early diagnosis of CHD permits parents to make the difficult choice of eventual interruption of pregnancy. The rates of prenatal diagnosis of CHD were 47,3% in France, 49% in USA, and 52,8% in Australia [10]. In our center, our 21 years' experience is in accord with the one of Khoshnood [6]: the spectrum of prenatally diagnosis CHD is getting similar to the one observed after birth. This is due to the great number of detected cases. Other than hypoplastic left heart syndrome (HLHS), pregnancy termination was exceptional. Early neonatal mortality in patients with severe CHD decreased to less than 1/3 in the period 1995– 2000 [6]. The curve of survival shows a slightly worse survival for neonates with the prenatal diagnosis but this is likely to be related to the composition of the population and selection bias since fetal echocardiography is performed only when there is a high index of suspicion for more severe CHD [11].

#### **4.1 Fetal cardiac intervention**

Several fetal studies reported that structural heart disease, in particular aortic stenosis, evolves in utero, hindering the growth of the left ventricle [12]. Fetal cardiac intervention (FCI) is a novel and advanced technique that allows in utero treatment of a subset of congenital heart disease. Fetal cardiac intervention with valvuloplasty, is based on the principle that intervention will modify the natural history of the disease process [13]. To prove an eventual favorable impact of FCI, we must first gain a full understanding of the unaltered progression of heart disease in utero. Referral centers that have performed the most procedures have shown that in utero valvuloplasty can be performed successfully, with limited risk to the mother and encouraging outcomes for fetuses, especially in those with aortic stenosis at risk of evolving to HLHS [14].

Fetal intervention is technically feasible only in a small specific subset of congenital heart defects.

The three most commonly performed FCI are [15]:

	- **Fetal aortic stenosis**. In Linz center between October 2000 and February 2020, 115 fetal aortic valvuloplasties (FAV) were undertaken in 95 fetuses. All patients but one had at least one technically successful procedure. An overall success rate of 82.4% (14/17 procedures) was reported by Tulzer et al. [16]. Similarly, Pickard et al. reported in a period from 2000 to 2017 that fetal aortic valvuloplasty was technically successful in 84% of 143 fetuses, while fetal demise was observed in 8%. Biventricular circulation was achieved in 50% of the remaining 111 liveborn infants with successful fetal aortic valvuloplasty, while only 16% of the 19 patients with unsuccessful valvuloplasty achieved biventricular circulation [17].
	- **HLHS with intact or restrictive atrial septum.** The incidence of intact atrial septum in HLHS is approximately 6%, with restrictive atrial septum occurring in up to 22% [18]. Survival for patients with HLHS and intact atrial septum remains poor, with a 1-year survival rate of ∼ 30% [19]. The rationale for FCI in HLHS with intact or restrictive atrial septum is to avoid severe neonatal hypoxia and death and to prevent worsening of the lung disease that frequently occurs as a result of chronic in utero pulmonary venous hypertension. Postnatal management involves atrial septostomy, the Rashkind procedure, to open the atrial septum and enhance atrial mixing. Some selected centers performing this type of FCI, have attempted to maintain patency of the atrial septal defect until the time of delivery, with an atrial septal stent. In the largest cohort of patients undergoing FCI on the atrial septum (n = 47) from the International Fetal Cardiac Intervention Registry, technical success was reported in 77% of cases, with 65% success in atrial stent placement [20].
	- **Pulmonary atresia/stenosis with an intact ventricular septum.** Even lesions like pulmonary atresia with intact ventricular septum and severe pulmonary stenosis can progress to significant right ventricular dysplasia and evolve to unfavorable univentricular circulation at birth which will require complex and multiple interventions in the follow-up. These fetuses are potential candidates for pulmonary balloon valvuloplasty in utero. Fetal cardiac intervention offers the potential for improved right ventricle and tricuspid valve growth, less damage to the myocardium, potential for biventricular circulation, and improved morbidity and mortality [21].

The International Fetal Cardiac Intervention Registry (IFCIR) has published data from multiple institutions that provide FCI for PA/IVS [22]. In this study, 16 patients enrolled underwent FCI with 11 successful procedures. The procedure success rate was 11/16 (69%). Of the 11 technically successful cases, five (45%) had postnatal biventricular repair [22]. The group at the Children's Hospital Heart Center in Linz has

### *The Impact of Fetal Echocardiography on the Prognosis of Congenital Heart Disease DOI: http://dx.doi.org/10.5772/intechopen.104828*

published a large cohort of patients at a single center [23]. They performed 35 FCI on 25 maternal-fetal pairs for either PA/IVS (n = 15) or critical pulmonary valve stenosis (n = 8). They report either partial or successful FCI in 21/23 maternal-fetal pairs. In the successful intervention group, 15 had a predicted biventricular surgery (70%), three a one and a half ventricle surgery and three an indeterminate outcome. No patients that had a successful FCI were predicted to have a single ventricle outcome [23]. A study performed at Boston Children's Hospital describes their experience [24]. FCI was performed in ten fetuses with PA/IVS. The first four procedures were technically unsuccessful and the following six procedures were successful. Compared with control fetuses (n = 15) with PA/IVS who did not undergo prenatal intervention and had univentricular outcomes after birth, the tricuspid valve annulus, right ventricle length, and PV annulus grew significantly more from midgestation to late gestation in the six fetuses who underwent successful interventions. Nine fetuses were liveborn; one fetus was terminated after an unsuccessful attempt at FCI. All nine patients required postnatal interventions. Of the six successful FCIs, five had a predicted biventricular outcome (83%) and one had a predicted single-ventricle outcome [24].

FCI also includes transplacental drug therapy, such as maternal antiarrhythmic drugs in case of fetal arrhythmias and steroids [25].

#### **4.2 Termination of pregnancy**

FCI techniques have made possible to improve the success rates of cardiac interventions in utero, obtaining better postnatal outcomes. However, it is inevitable to consider the consequences of a diagnosis of CHD in the prenatal period, leading to a set of complex emotional states in parents who move away from the concept of "healthy condition" of their future child. Discussion with parents on the long-term prognosis constitutes a fundamental element of adequate counseling. Appropriate counseling is ideally composed of an interdisciplinary team: obstetrician, pediatrician, pediatric cardiologist, and heart surgeon [26]. Counseling to parents following the diagnosis of congenital heart disease should take into account: the severity of CHD, the association with extracardiac malformations, and the presence of an associated genetic syndrome. All of these factors influence the parents' decision regarding pregnancy continuation or interruption.

In recent decades, the study of the heart in the prenatal period through fetal echocardiography, associated with a marked improvement in ultrasound technologies, and a greater competence of the operators, has significantly increased detection of the prenatal CHD. The incidence cardiac anomalies diagnosed at prenatal ultrasound screening differs from that observed at birth, due to intrauterine fetal demise and the recourse to termination of pregnancy (TOP). Indeed, in countries where prenatal evaluation is considered as standard of care, the incidence of CHD births is even lower [27]. As mentioned before, the main advantages of an early diagnosis of cardiac malformation are the possibility of adequate preparation for childbirth and neonatal care and early interventions in utero. However, it is inevitable to consider the consequences of a diagnosis of cardiac malformation have in the prenatal period, leading to a set of complex emotional states in parents who have to move away from the concept of "healthy condition" of their future child and eventually undertake the difficult choice of TOP [6]. Annually in the European Union, it has been estimated that 36000 children are live-born with CHD [28]. Increasing prenatal detection may lead to a reduced birth incidence of severe complex CHD through a high rate of TOP, even if this trend is not universal [29]. In the EUROCAT registry, a total of 31% of prenatally

diagnosed nonchromosomal CHD resulted in TOP [28]. The parent's choice to TOP is conditioned by several factors as listed below [30–32]:


Additional components that influence the couple's decision-making process include the socioeconomic status, the age of the parents, and the overall family context (caregivers) [33]. It is also reported in the literature that the "pressure" regarding the choice to terminate a pregnancy following multidisciplinary counseling is greater when listening to gynecologists than to pediatric cardiologists and cardiac surgeons [34]. A French study reports an interesting analysis of isolated CHD fetuses; concluding that more than half of the choices for termination of pregnancy were based on the "complexity" of heart disease as HLHS, univentricular heart, pulmonary valve atresia, aortic stenosis [6]. It is, therefore, essential to transfer adequate and precise counseling to the couple without limiting the decision-making process. Thus, considering the information that is offered to parents by pediatric cardiologists and cardiac surgeons regarding the diagnosis of hypoplastic left heart syndrome, it is not surprising that the choice for TOP will increase in this condition because this CHD has a poor post-natal outcome with an impact on the quality of life of the newborn, given the multistage palliative surgery and the surgical risks associated with each intervention [35]. After these considerations, we should if fetal echocardiography should be performed ignoring the consequence of such acts [36]. This debate is still ongoing today, asking questions about the impact that prenatal ultrasound diagnosis can have on the future of humanity [37, 38].

#### **4.3 Fetal counseling**

Since the prenatal diagnosis of fetal malformation has improved and it's now possible to detect or suspect a fetal malformation from the mid-gestation, it has been necessary to improve the counseling, paying attention to the ethical and psychological aspects related to this issue [39–42]. This is an important issue raised by the large and growing scientific literature on this argument [39–42]. As a consequence of these observations, many authors [43, 44] suggest that is necessary that counseling is performed by a multidisciplinary team comprising the obstetrician, the cardiologist, the surgeon, and the psychologist, in order to provide a fully comprehensive information to the parents. The passage from *paternalistic medicine* to *defensive medicine,* which recognizes

#### *The Impact of Fetal Echocardiography on the Prognosis of Congenital Heart Disease DOI: http://dx.doi.org/10.5772/intechopen.104828*

the patient's right to have full information, incites the doctor to tell the truth, even in the case of the inauspicious diagnosis of a life-threatening illness. During counseling, at the communicative level, the challenge is not "*whether to tell the truth, but* rather, *how to tell it".* Since CHD is a significant cause of morbidity and mortality in the newborns, its diagnosis may lead to a huge crisis in the affected families, considering the perceived implications of having an abnormality of such vital an organ. The severity of the crisis depends not only on the nature of the abnormality, but also upon its perceived seriousness and whether the defect is correctable. During the pregnancy, parents idealize the newborn and give him/her qualities, feelings, and capacities that they wish. The birth of a baby with a malformation is a sorrow including the death of the imagined child.

The majority of the diagnosis of fetal congenital heart disease occurs after the 18th week of gestation, when the mother already feels the first fetal movements, and the baby is part of her body [45]. During counseling, parents need to know if there is a possibility of repair and what is the risk of the procedures, and how will be the child's quality of life. Some authors analyzed the mother's desire for more information on prenatal diagnosis of fetal abnormality [46]. Some mothers preferred to have increased information upfront in order to "wrap their head around the disease," while other mothers felt that too much information upfront increased anxiety and would rather "cross that bridge when they came to it."

The explanation should possibly be given with both parents present, allowing each to provide support to the other, considering that the impact may be different on either parent, since each may perceive the abnormality differently.

#### **4.4 Genetic counseling**

The etiology of congenital heart disease is currently the focus of intense research.

The ideal genetic counseling for cardiovascular malformations includes a thorough understanding of the anatomy, management, and outcome of the particular defect, identification of other affected family members, and careful pedigree analysis for prediction of familial risks, identification of associated malformations or syndromes, and options for prenatal diagnosis [2]. Preferably, genetic counseling should be provided both by a clinical geneticist with adequate knowledge about cardiac defects and outcomes and by a pediatric cardiologist who has good knowledge and skills in genetic issues.

In the past, genetic counseling for isolated congenital cardiovascular malformations (i.e., without extracardiac malformations or syndromic diagnosis) was transmitted as an advice, with the use of overall recurrence risk for first-degree relatives of 2–5%. These malformations were reputed to be *multifactorial*, but recent studies suggest that specific *genetic* influences may be more important than previously recognized, and that certain malformations are more likely to have a stronger genetic component [47, 48].

A common genetic defect or pathogenetic mechanism may cause several apparently different forms of congenital cardiovascular malformations, as, for example, in case of chromosome 22q deletion, that cause a variety of conotruncal malformations and aortic arch anomalies [49, 50].
